Opening of Bids - Byer's Softball Complex Improvements Proj No 123-071 - Premium Concrete Services

Home Browse Search

6. Laboratory Retention Periods and Reports Specimen Retention. Specimens that are confirmed by the laboratory to be positive, adulterated, substituted, or nvalid will be retained by the laboratory in properly secured, long-term, frozen storage for at least one year. Any employee split specimen not sent to another laboratory for testing, will be retained by the laboratory for the same period of time that the primary specimen is retained and will be maintained under the same storage conditions. Within this one-year period, the MRO, the employee, the Company, PHMSA or other state agencies with jurisdiction, may request in writing that the specimens be retained for an additional period. If the laboratory does not receive the request to retain the specimen within the one-year period, the specimen will be discarded. Record Retention. All laboratory records pertaining to any test for this Company on its covered safety -sensitive employees will be retained for two years. The employer -specific data that is created by the laboratory for the laboratory statistical summary will be retained for two years. Within this two-year period, the MRO, the employee, the Company, PHMSA or other state agencies with jurisdiction, may request in writing that the records be retained for an additional period. If the laboratory does not receive the request to retain the records within the two-year period, the records will be discarded. Semi-annual Reports. The laboratory will prepare and send to the Company the aggregate employer- specific summary on a semi-annual basis. The format for this report is found in Part 40, Appendix B. Laboratory Quality Control Inspections. The laboratory shall permit inspections by the Company, the PHMSA Administrator, or if the Company s subject to the jurisdiction of a state agency, a representative of the state agency. Additionally, if the Company uses a C/TPA. that C/TPA may conduct a periodic inspection of the laboratory on the behalf of the companies that are clients of the C/TPA. 8. MRO Review of Drug Test Results Compliance. The Company will have, on staff or contract for the services of, an MRO who is a licensed physician with knowledge of drug abuse and is qualified under Part 40. The MRO will follow the requirements of Part 40 in carrying out the functions of the "independent and impartial gatekeeper of the drug testing process'. A full description of the DOT MRO requirements can be found in Part 40, Subpart G ("Medical Review Officers and the Verification Process", and Subpart H (Split Specimen Testing). The MRO will complete requalification/certification training every five years. The MRO will subscribe to the ODAPC list -serve website to keep current on any changes to the DOT alcohol and drug testing regulations. The MRO will act to investigate and correct problems where possible and notify appropriate parties (e.g., HHS, DOT, employers, service agents) where assistance is needed (e.g., cancelled or problematic tests, incorrect results). Duties. All :confirmed drug test results for the Company are received by the MRO directly from the laboratory. The MRO is responsible for the review of both negative and non -negative test results, review of the CCFs associated with each test, and to conduct quality control reviews of the MRO staff. The MRO will review and nterpret confirmed positive, adulterated, substituted, and invalid test results. The MRO will verify a confirmed positive test result for marijuana, cocaine, amphetamines, semi -synthetic opioids (i.e., hydrocodone, hydromorphone, oxycodone and oxymorphone), and/or PCP unless the employee presents a legitimate medical explanation for the presence of drug(s)/metabolite(s) in his or her system. In carrying out this responsibility, the MRO shall examine alternate medical explanations for any positive, adulterated, substituted or invalid test result. This action would include conducting a medical interview with the employee and review of the employee's medical history, or review of any other relevant biomedical factors, such as the results of a physical examination following an opioid positive. If the MRO determines that it is necessary, the MRO will request the laboratory test for D, L stereoisomers of amphetamine and methamphetamine or testing for tetrahydrocannabivarin (THC-V) when verifying lab results. Premium Concrete Services, Inc: PHMSA DRUG/ALCOHOL PLAN 26 CJ NATIONAL COMt''LIANCE MANAGEMENT SERVICE, INC. (NCMS) 2011 (update 20211. Tt,e MCMS plan is No &ubiad of e registpretl wpynyhl and is proloctatl by wpyright laws in the U.S. and elsa,vhere All n9hls eserved.